Skip to main content

Table 3 Association between plasma procalcitonin level at admission and all-cause in-hospital mortality in multivariable Cox proportional-hazards regression

From: Usefulness of procalcitonin at admission as a risk-stratifying biomarker for 50-day in-hospital mortality among patients with community-acquired bloodstream infection: an observational cohort study

Covariate

Hazard ratio

95% CI

P value*

AUROCa

(95% CI)

Model #1: Plasma PCT, ROC-defined threshold

0.688 (0.643–0.730)

 Procalcitonin > 4.24 ng/mL

2.01

1.30–3.11

0.002

 Age (years)

1.01

1.00–1.02

0.02

 Pathogen genus, Streptococcus

0.50

0.21–1.18

0.12

 Pathogen genus, Staphylococcus

1.13

0.70–1.83

0.62

 Pathogen genus, Klebsiella

1.57

0.79–3.13

0.20

Model #2: Plasma PCT quartiles

0.708 (0.664–0.750)

 Procalcitonin, quartiles

1.31

1.07–1.60

0.008

 Age (years)

1.01

1.00–1.02

0.02

 Pathogen genus, Streptococcus

0.51

0.22–1.22

0.13

 Pathogen genus, Staphylococcus

1.11

0.69–1.80

0.66

 Pathogen genus, Klebsiella

1.61

0.81–3.21

0.18

Model #3: Plasma PCT, 4th vs. 1st to 3rd quartiles

0.699 (0.655–0.741)

 Procalcitonin, 4th quartile

1.62

1.05–2.50

0.03

 Age (years)

1.01

1.00–1.02

0.01

 Pathogen genus, Streptococcus

0.49

0.21–1.16

0.10

 Pathogen genus, Staphylococcus

1.13

0.70–1.83

0.61

 Pathogen genus, Klebsiella

1.71

0.86–3.41

0.13

Model #4: Plasma PCT, 4th vs. 1st quartile

0.716 (0.652–0.774)

 Procalcitonin, 4th quartile

2.44

1.21–4.94

0.01

 Age (years)

1.01

0.99–1.02

0.31

 Pathogen genus, Streptococcus

0.50

0.15–1.70

0.27

 Pathogen genus, Staphylococcus

0.98

0.50–1.93

0.95

 Pathogen genus, Klebsiella

1.51

0.52–4.39

0.45

  1. Note. AUROC area under the receiver operating characteristic curve, PCT procalcitonin
  2. *Cox proportional-hazards regression using the forced entry method
  3. aAUROC of the prognostic indices generated by the Cox proportional-hazards regression model to discriminate between positive and negative cases